Company / Depreciation & Amortization
Bone Biologics Corp Depreciation & Amortization History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$50
FY2020
5-year range
$50 / $620
FY2017-FY2020
Trend
-47.9%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $96 to $50 over the past 2 years.
Based on SEC 10-K filings.
$50 in FY2020 with a 3-year CAGR of -56.8%.
Improved from $96 to $50 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -56.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -56.8%, indicating a declining trend.
- In FY2020, depreciation & amortization decreased 47.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $50 | -47.9% |
| FY2019 | $96 | +0.0% |
| FY2018 | $96 | -84.5% |
| FY2017 | $620 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026